Prevalence of DIAbetic RETinopathy and Impact of Genetic Factors in the Development of Diabetic Retinopathy of Patients With Type 1 and 2 Diabetes Mellitus in SlovaKia
NCT02232503 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4011
Last updated 2016-09-22
Summary
The aim of the study is to find out prevalence and individual stages of Diabetic Retinopathy in patients with type 1 and type 2 DM verified based on complex ophthalmologic measurements in Slovak Republic. The outcome of the project will be epidemiology survey, prevalence of diabetic retinopathy (DR) and diabetic macular edema (DME) in relation to type and duration of diabetes mellitus and risk factors. Project will also identify genetic factors linked with the diseases.
Conditions
Interventions
- GENETIC
-
Studied cohort
For the purpose of DNA isolation prior to genetic analysis of patients two samples of peripheral blood will be taken; first in the volume of 3.5 ml and second in the volume of 9 ml from each patient included into the study.
Sponsors & Collaborators
-
Medirex Group Academy
collaborator UNKNOWN -
Slovak Technical University
collaborator UNKNOWN -
Comenius University
collaborator OTHER -
Novartis Slovakia, s.r.o.
lead INDUSTRY
Principal Investigators
-
Dagmar Buckova, M.D. · Novartis Slovakia
-
Peter Carnogursky, MSc. · Novartis Slovakia, s.r.o.
-
Svetlana Sefcikova, MD · Novartis Slovakia, s.r.o.
-
Pavol Tison, MD · Novartis Slovakia, s.r.o.
-
Iveta Tvrda, MD · Novartis Slovakia, s.r.o.
-
Daniela Gasperikova, MSc., PhD. · Novartis Slovakia, s.r.o.
-
Ivana Hojsikova, RNDr. · Medirex Group Academy
-
Ludevit Kadasi, RNDr., DrSc. · Comenius University
-
Iwar Klimes, Prof., MD, DrSc. · Novartis Slovakia, s.r.o.
-
Peter Jackuliak, MD · University Hospital Bratislava
-
Vladimir Krasnik, MD PhD. · University Hospital Bratislava
-
Emil Martinka, MD, PhD. · National Institute for Endocrinology and Diabetology
-
Marian Mokan, Prof. MD DrSc. · Jesenius University Martin
-
Zuzana Nemethyova, MD · Diabetology Dispensary Bratislava
-
Marta Ondrejkova, MD PhD. · F.D. Roosevelt Hospital Banska Bystrica
-
Jana Stefanickova, MD · University Hospital Bratislava
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-02-28
- Primary Completion
- 2015-11-30
- Completion
- 2015-11-30
More Related Trials
-
Validation of a Predictive Model to Estimate the Risk of Conversion to Clinically Significant Macular Edema and/or Vision Loss in Mild Nonproliferative Diabetic Retinopathy in Diabetes Type 2
NCT00763802 ·Status: COMPLETED
-
Clinical Research on Retinal Neovascularization of Diabetic Retinopathy
NCT01229540 ·Status: TERMINATED ·Phase: NA
-
A Multi-center Study to Evaluate Performance of an Automated Device for the Detection of Diabetic Retinopathy
NCT02963441 ·Status: COMPLETED
-
RETeval Study for Diabetic Retinopathy
NCT01950663 ·Status: COMPLETED ·Phase: NA
-
DIabetic Retinopathy Candesartan Trials
NCT00252694 ·Status: COMPLETED ·Phase: PHASE3
-
Prevalence of DRP and DME Among Type 1 Diabetics Treated With Long-term Intensified Insulin Therapy
NCT02307110 ·Status: COMPLETED ·Phase: NA
-
Diabetic Macular Edema and Diabetic Retinopathy Screening (TeleMed) With Automated Retinal Photography
NCT01790945 ·Status: UNKNOWN
-
Clinical Decision Support Algorithm to Predict Diabetic Retinopathy
NCT03769948 ·Status: UNKNOWN
-
The Diabetic Retinopathy Screening, Prevention and Control Program
NCT04240652 ·Status: RECRUITING
-
Severe Proliferative Diabetic Retinopathy
NCT01115257 ·Status: COMPLETED ·Phase: NA
-
Study of Natural Course Progression of Diabetic Retinopathy
NCT06269419 ·Status: RECRUITING
-
Genetic Markers and Proliferative Diabetic Retinopathy
NCT02879422 ·Status: COMPLETED ·Phase: NA
-
Prevalence of DRP and DME Among Type 1 Diabetics Treated With Long-term Intensified Insulin Therapy
NCT03437551 ·Status: COMPLETED
-
Skin and Retina Microvascular Endothelial Function in Healthy, Insulin Resistant and Type 2 Diabetic Subjects
NCT01241370 ·Status: COMPLETED
-
Topical Application of Latanoprost in Diabetic Retinopathy
NCT01225653 ·Status: COMPLETED ·Phase: PHASE4
-
Combined Effects of Diabetes Self-Management Education and Nutritional Supplementation on Visual Function and Retinopathy
NCT04120077 ·Status: UNKNOWN ·Phase: NA
-
Fenofibrate in Type 2 Diabetes
NCT03829514 ·Status: COMPLETED ·Phase: PHASE4
-
Combined Antioxidant Therapy on Oxidative Stress, Mitochondrial Dysfunction Markers in Diabetic Retinopathy
NCT03702374 ·Status: COMPLETED ·Phase: PHASE3
-
DIabetic Retinopathy Candesartan Trials.
NCT00252720 ·Status: COMPLETED ·Phase: PHASE3
-
Diabetic Retinopathy and Visual Function Study
NCT00001346 ·Status: COMPLETED
-
A Clinical Study Evaluating the Safety, Tolerability and Initial Efficacy of SKG0106 Intravitreal Injection in Diabetic Macular Edema (DME) Patients
NCT06237777 ·Status: RECRUITING ·Phase: PHASE1
-
Comparison of Diabetes Retinopathy Among Type 2 Diabetic Patients Treated With Different Regimens
NCT02587741 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2798745 in Participants With Diabetic Macular Edema
NCT04292912 ·Status: TERMINATED ·Phase: PHASE1
-
Restoration of Retinal Vascular Responses in Type 1 Diabetic Patients
NCT02099981 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate the Efficacy and Safety of Combination Therapy With B55R1 and B55R2 Compared to B55R1 Monotherapy in Patients With NPDR
NCT07230184 ·Status: COMPLETED ·Phase: PHASE4